| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1169 | 2021 |
| Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission L Rivett, S Sridhar, D Sparkes, M Routledge, NK Jones, S Forrest, ... elife 9, e58728, 2020 | 616 | 2020 |
| Virus genomes reveal factors that spread and sustained the Ebola epidemic G Dudas, LM Carvalho, T Bedford, AJ Tatem, G Baele, NR Faria, DJ Park, ... Nature 544 (7650), 309-315, 2017 | 467 | 2017 |
| Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study LW Meredith, WL Hamilton, B Warne, CJ Houldcroft, M Hosmillo, ... The Lancet infectious diseases 20 (11), 1263-1271, 2020 | 463 | 2020 |
| Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission CL Brimacombe, J Grove, LW Meredith, K Hu, AJ Syder, MV Flores, ... Journal of virology 85 (1), 596-605, 2011 | 324 | 2011 |
| Hepatitis C virus infects the endothelial cells of the blood-brain barrier NF Fletcher, GK Wilson, J Murray, K Hu, A Lewis, GM Reynolds, ... Gastroenterology 142 (3), 634-643. e6, 2012 | 290 | 2012 |
| Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days B Diallo, D Sissoko, NJ Loman, HA Bah, H Bah, MC Worrell, LS Conde, ... Clinical infectious diseases 63 (10), 1353-1356, 2016 | 273 | 2016 |
| Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication PL Chavali, L Stojic, LW Meredith, N Joseph, MS Nahorski, TJ Sanford, ... Science 357 (6346), 83-88, 2017 | 187 | 2017 |
| COMRADES determines in vivo RNA structures and interactions O Ziv, MM Gabryelska, ATL Lun, LFR Gebert, J Sheu-Gruttadauria, ... Nature methods 15 (10), 785-788, 2018 | 181 | 2018 |
| Patterns of within-host genetic diversity in SARS-CoV-2 G Tonkin-Hill, I Martincorena, R Amato, ARJ Lawson, M Gerstung, ... elife 10, e66857, 2021 | 156 | 2021 |
| Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases A Arias, SJ Watson, D Asogun, EA Tobin, J Lu, MVT Phan, U Jah, ... Virus evolution 2 (1), vew016, 2016 | 143 | 2016 |
| Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, ... Nature communications 11 (1), 6385, 2020 | 116 | 2020 |
| Hepatitis C virus entry: beyond receptors LW Meredith, GK Wilson, NF Fletcher, JA McKeating Reviews in medical virology 22 (3), 182-193, 2012 | 114 | 2012 |
| Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies A Meola, AW Tarr, P England, LW Meredith, CP McClure, SKH Foung, ... Journal of virology 89 (4), 2170-2181, 2015 | 96 | 2015 |
| An alpaca nanobody inhibits hepatitis C virus entry and cell‐to‐cell transmission AW Tarr, P Lafaye, L Meredith, L Damier‐Piolle, RA Urbanowicz, A Meola, ... Hepatology 58 (3), 932-939, 2013 | 86 | 2013 |
| Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... Cell Reports Medicine 1 (6), 2020 | 81 | 2020 |
| Entry of hepatitis B and C viruses—recent progress and future impact TF Baumert, L Meredith, Y Ni, DJ Felmlee, JA McKeating, S Urban Current opinion in virology 4, 58-65, 2014 | 79 | 2014 |
| Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses AM Chmielewska, M Naddeo, S Capone, V Ammendola, KE Hu, ... Journal of virology 88 (10), 5502-5510, 2014 | 75 | 2014 |
| Potent inhibition of HIV-1 replication by a Tat mutant LW Meredith, H Sivakumaran, L Major, A Suhrbier, D Harrich PloS one 4 (11), e7769, 2009 | 73 | 2009 |
| Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor‐dependent manner NF Fletcher, R Sutaria, J Jo, A Barnes, M Blahova, LW Meredith, ... Hepatology 59 (4), 1320-1330, 2014 | 64 | 2014 |
